| Rachel Darlene Tate, | |
|
325 Maine St, Lawrence, KS 66044-1360 | |
| (785) 505-2522 | |
| Not Available |
| Full Name | Rachel Darlene Tate |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse |
| Location | 325 Maine St, Lawrence, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013473388 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | 13-111338-022 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Darlene Tate, 325 Maine St, Lawrence, KS 66044-1360 Ph: (785) 505-2522 | Rachel Darlene Tate, 325 Maine St, Lawrence, KS 66044-1360 Ph: (785) 505-2522 |
News Archive
In response to the millions of federal dollars available to healthcare providers who install electronic patient records systems in their facilities, the Colorado Rural Health Center (CRHC) and ClinicNET's "The Forum 2010" will focus primarily on Health Information Technology (HIT). The event, held in Aurora, CO, runs from April 19-21.
Carrier screening provides you and your doctor with information about your risks of having a child with a serious genetic disease prior to or during pregnancy.
Eli Lilly and Company announced today that its investigational medicine for prevention of migraine (LY2951742, a CGRP neutralizing antibody) met the primary endpoint in a Phase 2b study in episodic migraine.
Public health nurses with the Sudbury and District Public Health Unit are going to conciliation in their bid to reach a new contract with their employer. Conciliation dates have been set for November 3 and 4, 2009.
EpiCept Corporation today announced that it has reached an agreement on all outstanding issues with the U.S. Food and Drug Administration (FDA) on a regulatory path forward for Ceplene® (histamine dihydrochloride), the Company's lead product for the remission maintenance and prevention of relapse of patients with acute myeloid leukemia (AML) in first complete remission. Ceplene® is approved in the European Union for this indication and is marketed there by Meda AB.
› Verified 3 days ago
Leticia Oberley, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 916 Kentucky St Apt 3, Lawrence, KS 66044 Phone: 913-416-2098 | |
Mrs. Patricia Gail Hohman, ARNP CDE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 325 Maine St, Lawrence, KS 66044 Phone: 785-505-5000 Fax: 785-505-2581 | |
Robin Byer, RN CWON Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2046 New Hampshire St, Lawrence, KS 66046 Phone: 785-843-4331 | |
Mr. David Emroy Cornelius, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2415 Massachesetts, Lawrence, KS 66046 Phone: 785-843-3750 Fax: 785-832-4887 | |
Mrs. Rachel Hanna Harrington, APRN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 2415 Massachusetts St, Lawrence, KS 66046 Phone: 785-832-4840 | |
Brittnay Schuetz, Registered Nurse Medicare: Medicare Enrolled Practice Location: 200 Maine St Ste A, Lawrence, KS 66044 Phone: 785-843-3060 |